Carisbamate (YKP 509, proposed trade name Comfyde) is an experimental anticonvulsant drug that was under development by Johnson & Johnson Pharmaceutical Research and Development but never marketed.

Property Value
dbo:abstract
  • Carisbamate (YKP 509, proposed trade name Comfyde) is an experimental anticonvulsant drug that was under development by Johnson & Johnson Pharmaceutical Research and Development but never marketed. (en)
dbo:thumbnail
dbo:wikiPageEditLink
dbo:wikiPageExtracted
  • 2019-06-04 01:34:40Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 10600394 (xsd:integer)
dbo:wikiPageLength
  • 4461 (xsd:integer)
dbo:wikiPageModified
  • 2019-06-04 01:29:19Z (xsd:date)
dbo:wikiPageOutDegree
  • 14 (xsd:integer)
dbo:wikiPageRevisionID
  • 900191738 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • Carisbamate (YKP 509, proposed trade name Comfyde) is an experimental anticonvulsant drug that was under development by Johnson & Johnson Pharmaceutical Research and Development but never marketed. (en)
rdfs:label
  • Carisbamate (en)
owl:sameAs
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is foaf:primaryTopic of